JOHN M. FLACK, M.D., M.P.H., earned his undergraduate degree in
Chemistry from Langston University in Langston, Oklahoma and subsequently
attended the University of Oklahoma School of Medicine where he was a member
of the Alpha Omega Alpha (AOA) Medical Honor Society. Dr. Flack also completed
his Internal Medicine residency training at the University of Oklahoma Health
Sciences Center. During 1985-86, he was Chief Medical Resident. He subsequently
was an Instructor of Medicine (1986-88) and Associate Director of the Hypertension
Center at the same institution. Between 1988 and 1990, Dr. Flack was a National
Heart Lung and Blood Institute (NHLBI) postdoctoral fellow in Preventive
Cardiology at the University of Minnesota School of Public Health. During
his fellowship he earned a Master of Public Health (MPH) degree in epidemiology.
For the ensuing two years Dr. Flack was an Assistant Professor at the University
of Minnesota School of Public Health Division of Epidemiology and was Principal
Investigator on two NHLBI-funded studies: The Treatment of Mild Hypertension
Study (TOMHS) and the Coronary Artery Risk Development in Young Adults (CARDIA)
Study. He was Co-Principal Investigator on the NHLBI-funded Sodium Sensitivity
in Blacks Study. Between 1992 and 1994, Dr. Flack was also Section Chief
of General and Preventive Medicine at the University of Minnesota Medical
School. In August of 1994, he moved to Bowman Gray Medical School as an
Associate Professor of Surgery, Medicine, and Public Health Sciences and
Associate Director and Medical Director of the Hypertension Center Clinical
Facilities.
In
July of 1997, he moved to Wayne State University,
School of Medicine in Detroit Michigan, as Associate
Chairman for the Department of Medicine and started
the Cardiovascular Epidemiology and Clinical
Applications (CECA) Program. Dr. Flack, a Professor
of Medicine and Physiology, holds an appointment in
the Division of Endocrinology, Metabolism, and
Hypertension at Wayne State University, and is Chief
of the Division of Translational Research and
Clinical Epidemiology (TRaCE) and Interim Chair,
Department of Medicine. Dr. Flack is also the
Principal Investigator for the NIH/NIEHS funded
Center for Urban and African American Health (www.cuaah.org).
Dr. Flack has published over 150 peer-reviewed manuscripts, editorials and book chapters in the areas of Hypertension Therapeutics, Salt and Blood Pressure, and Cardiorenal Epidemiology. He is a manuscript reviewer for approximately 30 peer-reviewed medical journals including Ethnicity and Disease, JAMA, Hypertension, Circulation, the American Journal of Medicine. He also serves on the editorial boards of Ethnicity and Disease, Hypertension, Therapeutic Advances in Cardiovascular Disease, the Journal of the Cardiometabolic Syndrome, Current Hypertension Reviews, and Internal Medicine/Cardiology News.
Dr. Flack has been repeatedly selected as on of the “Top Doctors” and “Best Doctors in America.” He has received numerous awards including the Searle Distinguished Research Award from the International Society of Hypertension in Blacks (ISHIB) (1993), the Daniel D. Savage Memorial Scientific Award from the Association of Black Cardiologists (1998), the Pillar of Excellence Award for Reducing Health Disparities from the Michigan Peer Review Organization (2005), the Crain's Detroit Business Health Care Hero Award for Outstanding Physician Achievement (2005), and the American Heart Association's Forest Dewey Dodrill Award for Excellence (2007). He is a member of Alpha Omega Honor Society, the Psychosocial Risk and Disease Prevention NIH Study Section, and the Environmental Health Sciences Review Committee (NIEHS). Dr. Flack is a member of the Advisory Board of the Council for the Advancement of Diabetes Research and Education (CADRE).
Dr. Flack is an expert in cardiovascular diseases (CVD) and specializes
in the area of hypertension in minority populations. He is frequently invited
to lecture to various health professionals nationally and internationally.
Some of his current research interests include: CVD risk factors in minority
populations and the influence of the renin-angiotensin-aldosterone-kinin
system on mediating salt-sensitivity and target-organ damage in African-Americans. |
